Soligenix
SNGX
#10246
Rank
NZ$24.71 M
Marketcap
NZ$2.45
Share price
5.22%
Change (1 day)
-39.45%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -NZ$21.42 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$16.25 Million a decrease over its 2023 earnings that were of -NZ$13.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$21.42 Million31.78%
2024 -NZ$16.25 Million22.96%
2023 -NZ$13.22 Million-45.74%
2022 -NZ$24.36 Million11.88%
2021 -NZ$21.77 Million-32.37%
2020 -NZ$32.19 Million83.18%
2019 -NZ$17.57 Million11.57%
2018 -NZ$15.75 Million19.29%
2017 -NZ$13.2 Million33%
2016 -NZ$9.93 Million-19.7%
2015 -NZ$12.36 Million5.16%
2014 -NZ$11.76 Million
2010 -NZ$13.27 Million26.12%
2009 -NZ$10.52 Million75.1%
2008 -NZ$6.01 Million-45.38%
2007 -NZ$11 Million-22.84%
2006 -NZ$14.26 Million66.15%
2005 -NZ$8.58 Million-16.65%
2004 -NZ$10.3 Million13.28%
2003 -NZ$9.09 Million-11.88%
2002 -NZ$10.32 Million-59.44%
2001 -NZ$25.43 Million378.18%
2000 -NZ$5.32 Million-38.53%
1999 -NZ$8.65 Million-18.43%
1998 -NZ$10.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cleveland BioLabs
CBLI
-NZ$4.79 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.81 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$20.60 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.31 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$72.6 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.56 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.08 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel